Atlantic Health treats first patient in Northeast for brain tumor with new cellular immunotherapy

Atlantic Health treats first patient in Northeast for brain tumor with new cellular immunotherapy

Atlantic Health said Dec. 22 that it is treating the first patient in the Northeast using a new cell therapy to treat glioblastoma, an aggressive primary brain tumor, as part of a Phase 2 clinical trial. The initial patient at Atlantic Health is being treated collaboratively at Morristown Medical Center and Overlook Medical Center in Summit, by the Atlantic Medical Group neuro-oncology and Atlantic Brain and Spine neurosurgery teams. Glioblastom…